23 results
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
a 3-point improvement in mADL11
14 Essential3: An innovative Phase 3 program that optimizes all aspects of study conduct Single Recruiting Expert
8-K
EX-3.1
9g6qlnvjluvr7 rw38
7 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
424B4
wvf4sejh
14 May 21
Prospectus supplement with pricing info
4:34pm
DEF 14A
hsswa
29 Apr 21
Definitive proxy
4:04pm
10-K
8vo3j2aiorw7qi
17 Mar 21
Annual report
8:33am
8-K
EX-3.2
5fc85
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:20pm
424B4
n6o6o1
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1
EX-10.15
lep6q4
25 Sep 20
IPO registration
5:19pm
S-1
0bbaqr2c9corc4f9yvi
25 Sep 20
IPO registration
5:19pm
S-1
EX-10.16
55ipay3m7vmdftn
25 Sep 20
IPO registration
5:19pm
S-1
EX-3.4
aq3564nb8xedo8
25 Sep 20
IPO registration
5:19pm
DRS/A
EX-10.17
tdoftyu672s57
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
ro2ltnj5vzgbxp0rkcxb
28 Aug 20
Draft registration statement (amended)
12:00am